FeelGood vs Gala: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Gala beats FeelGood overall, scoring 7.2/10 vs 7/10. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa.

A side-by-side comparison of FeelGood and Gala covering pricing, scores, medication types, insurance, and more to help you decide.

FeelGood

#48 of 49

7/10

Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.

Visit FeelGood

Higher Rated

Gala

#40 of 49

7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

Feature	FeelGood	Gala
Our Score	7/10	7.2/10
Starting Price	$149/mo	$149/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging
Ranking	#48	#40

Pros & Cons Compared

FeelGood

Pros

+Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
+Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients — a non-injectable route only a handful of platforms provide
+LegitScript-approved — independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
+Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included

Cons

−Does NOT publicly disclose which US states it serves — you can't confirm availability in your state before starting an intake
−$149 is a 'starting' price (dose-escalating), not flat across all doses — your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
−Brand-name 'original' semaglutide injection at $1,999/mo is far above market — NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
−No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site — thin corporate and clinical transparency
−Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
−Compounded GLP-1s are not FDA-approved (none are) — and FeelGood offers compounded semaglutide only, no tirzepatide

Gala

Pros

+Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
−Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
−Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Our Verdict

Gala edges out FeelGood with a score of 7.2/10 vs 7/10. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither FeelGood nor Gala feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review